After prostate cancer treatment, a new standard of care for rising PSA
It isn’t often that a study leads to fundamental changes in how cancer patients are treated. But new research is doing just that for some men with prostate cancer that recurs after initial treatment. Post-treatment recurrence The first sign of recurrence is typically a rise in blood levels of prostate-specific antigen (PSA). PSA should drop…